Literature DB >> 2696323

Surgical margin in soft tissue sarcoma. The Scandinavian Sarcoma Group experience.

A Alho1, T A Alvegård, O Berlin, J Ranstam, A Rydholm, B Rööser, B Stener.   

Abstract

Two-hundred and forty adult patients with a high-grade soft tissue sarcoma were treated surgically in 18 hospitals participating in the Scandinavian Sarcoma Group Protocol I. The patients were randomized to either postoperative doxorubicin or control; patients whose surgical margin was judged marginal also received radiotherapy. The outcome after different surgical margins was analyzed in 185 tumors of Grades III or IV in the extremities. The total cumulative local tumor control was 91 percent (168 of 185) after a median of 47 months. The cumulative local control rates in the surgical groups were: compartmental or wide amputation--37/37 (100 percent), compartmental local excision--23/24 (96 percent), wide local excision--77/84 (92 percent), marginal excision and radiotherapy--19/21 (90 percent), and marginal excision alone (reevaluated margin)--12/19 (63 percent, significantly lower than others). The risk of local recurrence was 13 times higher after marginal than after compartmental surgery (P = 0.02) and 3 times higher if the tumor was larger than 10 cm (P = 0.05). The treatment with doxorubicin did not influence the risk of local recurrence. The survival rates did not differ significantly in the groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2696323     DOI: 10.3109/17453678909149605

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  11 in total

1.  [Surgical margins in soft tissue sarcoma of the extremities].

Authors:  H-U Steinau; L Steinsträsser; S Langer; I Stricker; O Goertz
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

2.  Soft tissue sarcoma of the extremity.

Authors:  T M Cooper; M Sheehan; D Collins; T P O'Connor
Journal:  Ann R Coll Surg Engl       Date:  1996-09       Impact factor: 1.891

3.  Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.

Authors:  S Singer; J M Corson; R Gonin; B Labow; T J Eberlein
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

4.  Soft tissue sarcomas of the extremities and trunk in the adult. Report of 124 cases.

Authors:  C Zornig; H J Weh; A Krüll; R Schwarz; R E Hilgert; S Schröder
Journal:  Langenbecks Arch Chir       Date:  1992

5.  The Width of the Surgical Margin Does Not Influence Outcomes in Extremity and Truncal Soft Tissue Sarcoma Treated With Radiotherapy.

Authors:  Rima Ahmad; Alex Jacobson; Francis Hornicek; Alex B Haynes; Edwin Choy; Gregory Cote; G Petur Nielsen; Yen-Lin Chen; Thomas F DeLaney; John T Mullen
Journal:  Oncologist       Date:  2016-07-20

6.  Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline.

Authors:  R Kandel; N Coakley; J Werier; J Engel; M Ghert; S Verma
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

7.  High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy.

Authors:  Benedikt Leidinger; Thomas Heyse; Andreas Schuck; Horst Buerger; Philipp Mommsen; Thomas Bruening; Susanne Fuchs; Georg Gosheger
Journal:  BMC Cancer       Date:  2006-06-18       Impact factor: 4.430

8.  The Use of Radiation Therapy in Well-Differentiated Soft Tissue Sarcoma of the Extremities: An NCDB Review.

Authors:  Alexander L Lazarides; William C Eward; Paul J Speicher; Chun-Han Hou; Daniel P Nussbaum; Cindy Green; Dan G Blazer; David G Kirsch; Brian E Brigman
Journal:  Sarcoma       Date:  2015-05-07

9.  Impact of surgical margin on survival in extremity soft tissue sarcoma: A systematic review and meta-analysis.

Authors:  Woo Young Jang; Han-Soo Kim; Ilkyu Han
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

10.  Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.

Authors:  T Brodowicz; E Schwameis; J Widder; G Amann; C Wiltschke; M Dominkus; R Windhager; P Ritschl; R Pötter; R Kotz; C C Zielinski
Journal:  Sarcoma       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.